Clin2
NCT06986304Possibly a fitRecruiting

Super-Resolution Ultrasound for Bladder Cancer

Bladder Cancer

Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.

This study uses a special ultrasound technique to take detailed pictures of the tiny blood vessels around bladder cancer. The goal is to help doctors better understand the cancer before surgery to remove the bladder.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years of age or older.
  • You have been diagnosed with a type of bladder cancer called urothelial cancer (also known as transitional cell carcinoma).
  • Your doctor has recommended surgery to remove your bladder (radical cystectomy).
  • You are not allergic to sulfur hexafluoride or polyethylene glycol (PEG), which are used in the ultrasound contrast agent or in some vaccines.
  • You are not pregnant or breastfeeding.
  • You do not have a serious unstable condition, such as being in the hospital intensive care unit or having a high-risk heart condition.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05204108Recruiting
Ultrasound test to check bladder cancer muscle spread

This trial studies a special ultrasound scan with contrast dye to see whether bladder cancer has grown into the muscle layer. It may help doctors plan the best treatment before surgery.

Guangzhou, Guangdong
NCT06775977Recruiting
Ultrasound contrast for bladder cancer staging

This trial uses a special ultrasound with contrast dye to get a clearer picture of bladder cancer before any treatment. It aims to improve how doctors determine the stage of the cancer, which helps guide the best treatment plan.

Guangzhou, Guangdong
NCT05810623Not yet recruiting· Phase 3
Single-dose bladder chemotherapy after diagnostic scope for upper urinary tract cancer

This study tests whether giving a single dose of chemotherapy directly into the bladder right after a diagnostic scope procedure can help prevent the cancer from coming back in people with a new diagnosis of cancer in the kidney or ureter. It is an extra step that may reduce the risk of recurrence without delaying standard care.

Vienna
NCT06679920Recruiting
New imaging probe to improve bladder cancer diagnosis

This trial tests a new optical probe that gives doctors a clearer view of bladder tumors during cystoscopy. It may help make diagnosis and treatment more accurate.

Amsterdam, North Holland
NCT07051083Recruiting
Bladder cancer staging trial using AI on imaging scans

This trial uses artificial intelligence to look at ultrasound and other scans to better stage bladder cancer and predict if chemotherapy before surgery might work. It may help doctors plan your treatment more precisely.

Guangzhou, Guangdong
NCT07424560Recruiting
Bladder Cancer DNA Testing Study

This study looks for specific DNA changes in bladder cancer tumors using a precise test. It aims to better understand the disease and may help guide future treatment choices.

Lanzhou, Gansu

Hear when a new Bladder Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.